Among the functions of intracellular proteolysis are the elimination of abnormal proteins, the maintenance of amino acid pools in cells during stresses such as starvation, and the generation of protein fragments that act as hormones, antigens, or other effectors. Yet another role of proteolytic pathways is to confer short half-lives on proteins whose concentrations must vary with time or alterations in the state of a cell. Thus, either a constitutive or a transient metabolic instability is a property of many regulatory proteins. Many other proteins, while long-lived as components of larger complexes, such as ribosomes and oligomeric proteins, are metabolically unstable as free subunits (for recent reviews, see references 15, 20, 22, 28, 34, 36, and 45) .
Amino acid sequences, conformational determinants, or chemically modified protein structures that confer metabolic instability are called degradation signals, or degrons (44) . An essential component of one degradation signal is the N-terminal residue of the protein (2) . The presence of this signal, called the N-degron, is manifested as the N-end rule, which relates the in vivo half-life of a protein to the identity of its N-terminal residue. Distinct versions of the N-end rule have been shown to operate in all organisms examined, from mammals to bacteria (reviewed in reference 45) .
In eukaryotes, linear ubiquitin (Ub) fusions to a test protein, such as P-galactosidase (Pgal) , are rapidly and precisely deubiquitinated by endogenous Ub-specific processing proteases (2 for generating different residues at the N termini of otherwise identical test proteins led to the discovery of the N-end rule in eukaryotes (2) . Subsequent isolation of UBP1, the gene encoding one of the Ub-specific processing proteases of the yeast Saccharomyces cerevisiae (43) , and expression of this enzyme in Escherichia coli made possible the use of Ub fusions to test for the presence of an N-end rule in bacteria, which lack Ub and Ub-specific enzymes. Tobias and colleagues detected and defined the N-end rule in E. coli and also showed that the gene aat is required for the degradation of N-end rule substrates that bear N-terminal Arg or Lys, whereas all classes of N-end rule substrates (i.e., those bearing N-terminal Phe, Leu, Trp, Tyr, Arg, or Lys) are stabilized by disruptions of the gene clpA (42) . The previously cloned clpA encodes a subunit of ATP-dependent protease Clp (also known as protease Ti; for reviews, see references 18 and 20) . The aat locus was originally defined by use of a mutant that lacked the activity of leucyl, phenylalanyl-tRNA-protein transferase (L/F-transferase), an enzyme that conjugates Leu or Phe to Arg or Lys at the N termini of test substrates (40) . The function of this enzyme, which is present in bacteria but not in eukaryotes, was revealed by the finding that N-end rule substrates bearing N-terminal Arg or Lys are short-lived in E. coli in the presence but not in the absence of L/F-transferase (42) .
The N-end rule is thus organized hierarchically, with N-terminal Arg and Lys being secondary destabilizing residues, in that they function as substrates for the conjugation of either Leu or Phe, two of the four primary destabilizing residues (Leu, Phe, Trp, and Tyr) in the E. coli N-end rule.
The N-end rule is also hierarchical in eukaryotes, but the details are quite different (19) . For example, in the yeast S. cerevisiae, N-terminal Arg and Lys are primary destabilizing residues, while N-terminal Asp and Glu are secondary destabilizing residues, in that they function as substrates for the conjugation of Arg, one of the primary destabilizing residues in eukaryotes. The conjugating enzyme, arginyltRNA-protein transferase (R-transferase), is not found in bacteria (14) .
The present work extends our initial findings about the E. coli N-end rule (42) . First, we describe the cloning and analysis of the aat gene. Second, an N-end rule substrate, such as Arg-pgal (a 3-gal variant engineered to expose an N-terminal arginine), is modified in vivo through the N-terminal conjugation of Leu but not of Phe. Third, aat is only -1 kb away from the previously characterized, convergently transcribed cipA gene, which encodes a subunit of protease Clp, another component of the N-end rule pathway. Finally, the aat gene is part of a new operon that also encodes a homolog of the mammalian multidrug resistance (Mdr) P glycoproteins.
MATERIALS AND METHODS
Bacterial strains and media. E. coli MC1061 [hsdR mcrB araD139 A(araABC-leu)7679 AlacX74 galU galK rpsL thi] was used as the parental strain throughout this work. Variants of this strain were constructed by P1 transduction (38) .
In particular, strain TS360 (MC1061 recD1903::minitet), which allows targeted homologous recombination to be carried out by transformation with linear DNA fragments, was constructed from MC1061 by use of a Plvir lysate grown on strain DPB271 (recD1903::minitet) (6 The solid medium contained 2% Bacto Agar (Difco). Antibiotics (Sigma) were added as needed to the following final concentrations: 100 ,g of ampicillin, 10 ,g of tetracycline, 34 ,ug of chloramphenicol, and 25 ,ug of kanamycin per ml. 5-Bromo-4-chloro-3-indolyl-13-D-galactopyranoside (X-Gal; Boehringer), a chromogenic Pgal substrate, was added as needed to 0.006%.
Plasmids. Plasmid pAS1 is a derivative of pBR322 (8) that was constructed by replacing the -2-kb EcoRI-PvuII fragment of pBR322 with a -0.12-kb EcoRI-PvuII fragment of pGEM2-Ava that contains a polylinker cloning region (37) .
Each of the pUBP-X-fgal plasmids expressed both the Ub-specific processing protease Ubpl of S. cerevisiae and 1 of the 20 Ub-X-Pgal fusion proteins (where X is any amino acid) (see above). This set of plasmids was constructed by isolating the -5.3-kb ScaI fragments of pUB23-X plasmids (2) , which encode the Ub-X-Pgal fusion proteins, ligating BglII linkers to the ends of the fragments, and inserting each of the fragments into the BamHI site of plasmid pJT184, which encodes Ubpl (43) . The resulting pUBP-X-,Bgal plasmids expressed Ub-X-fgal and Ubpl from yeast promoters that are weakly active in E. coli (42) . These plasmids contained the plSA replicon and a cat gene from plasmid pACYC184 that conferred, respectively, compatibility with ColEl replicon-based plasmids and resistance to chloramphenicol (11) . The construction of other plasmids is described below.
Transposon mutagenesis. Minitet transposon insertions into the E. coli chromosome that inhibited the degradation of normally short-lived Arg-IBgal were generated by the "Xhop" method (46) . In brief, MC1061 cells carrying the pUBP-R-iBgal plasmid were infected with XNK1098 (46), plated on medium containing tetracycline, and screened for tetracycline-resistant (Tetr) colonies. MC1061 is supo and therefore does not support the replication or integration of XNK1098, which carries a Pam8O amber mutation in its P gene and the b522 deletion, which removes the phage attachment site. Thus, a Tetr colony would be derived from a cell in which the minitet transposon of XNK1098 has "hopped" from the phage into the E. coli chromosome. Minitet transposon insertions that inhibit Arg-13gal degradation result in elevated intracellular levels of Arg-jBgal; such cells form blue colonies in the presence of X-Gal (see Results and reference 42). Approximately 15,000 Tetr colonies were screened for high Arg-IBgal levels on X-Gal plates. Putative Arg-13gal degradation mutants were tested further by curing the cells of pUBP-R-Pgal through growth in the absence of chloramphenicol and retransforming cured cells with independently isolated pUBP-X-Pgal plasmids.
Identification of minitet insertion sites. The insertion sites were determined by direct sequencing of minitet-E. coli DNA junctions. Total DNA from mutants TS351 and TS357, which were defective in the degradation of Arg-pgal (see Results), was prepared (38) and digested with BamHI. Since BamHI does not cut within the minitet sequence, complete digestion yields a minitet-containing DNA fragment flanked on both sides with E. coli DNA. Minitet-containing fragments were isolated by ligating the BamHI-produced E. coli DNA fragments into BamHI-digested pAS1, transforming the resulting library into TS365, and selecting for Tetr transformants. TS365 contains a mutation in the pcnB gene that lowers the copy number of ColEl-like plasmids such as pBR322 and pAS1 (32) and therefore allows the use of the TnlO-derived tet gene, which is lethal when expressed from a multicopy plasmid in wild-type cells (29) . For preparation of larger quantities of minitet-E. coli DNA junctions for sequencing, minitet-containing BamHI fragments were digested with EcoRI, which cuts within the tet gene, yielding fragments that were no longer lethal at a high copy number. These fragments were ligated into BamHI-EcoRI-cut pAS1 and transformed into MC1061. Plasmid DNA was isolated from transformants by the alkaline lysis procedure (1). Nucleotide sequencing was carried out by the chain termination method with standard procedures (1) and primers complementary to the ends of the minitet element (47) . The sequences of the actual minitet insertion sites, 5'-CACA CAGCA-3' (TS351 mutant) and 5'-CGCAAAGCA-3' (TS357 mutant), were similar to the consensus sequence for TnJO insertions, 5'-NGCIJNAGCN-3' (29) . These sequences are identical to positions 2363 to 2371 of Fig. 1 , which lie within the aat gene (see below), and to positions 2773 to 2781 of the previously published sequence of the clpA gene (21) ; the latter positions correspond to positions 4592 to 4584 in the numbering scheme of Fig. 1 .
Mapping, cloning, and sequencing of the aat gene. Hfr and P1 mapping of the class I and II minitet insertions (see Results) , which inhibited the degradation of Arg-,Bgal, was performed as described previously (38) with mutants that carried pUBP-R-13gal. Inclusion of this plasmid allowed for easy monitoring of the ability of a particular Hfr donor strain or Plvir lysate to correct the mutant cell's defect in Arg-,Bgal degradation. The restoration of Arg-pgal degradation by Hfr mating or P1 transduction resulted in the appearance of white colonies on X-Gal plates. Polymerase chain reaction mapping was carried out with a GeneAmp kit (Perkin-Elmer VOL. 175, 1993 4366 SHRADER ET AL.
GGAATTTATCGGTCATGGCGGTAAGCTTATCGACTGCCAGGTCCTTAACGATCACACAGCATCGCTTGGTGCCTGCGAAATTCCCCGCCGGGATTACCTTAATTA 2415 (21) . The putative Shine-Dalgarno sequences for mdrH, aat, and infA are underlined. Nucleotide sequence data for a portion of this region have been published elsewhere (12, 21) . Our data differ from those published in reference 12 at positions 3585 (no nucleotide in reference 12), 1583 (C in reference 12), and 1620 (no nucleotide in reference 12). These differences result in an alteration of the deduced amino acid sequence of the MdrH protein encoded by this region. In addition, our sequence data differ from those reported in reference 21 at positions 3585 (no nucleotide in reference 21) and 3602 (no nucleotide in reference 21). (9) . The pAS45 vector used in the second deletion series was constructed by inserting the BglII-SspI fragment that contained the aat gene (Fig. 2) into BamHI-PvuII-cut pAS44. For the deletion series, pAS45 was digested with SacI and AvaI, creating a linear fragment with a 3' overhang immediately downstream of the T14 terminator and a 5' overhang 389 bp upstream of the aat start codon. Deletions from the 5' overhang were made, and the resulting fragments were recircularized as described above. Ligation products were transformed into TS351 containing pUBP-R-Pgal as described above.
Plasmids pAS31 and pAS32 were constructed by inserting the PvuII (a site within pGEM2)-SspI (position 2,791 in Fig.  1 ) fragment from deletion clones W1 and W3 (see Fig. 4A ) into the EcoRV site of pBR322. Plasmid pAS25 was constructed from pAS17 by deleting the 346-bp KpnI fragment that spans the region from the 3' end of the aat gene to the 5' end of the infA gene (see Fig. 4A ).
N-terminal sequence analysis of an N-end rule substrate. Isolates of E. coli JT111 (lacIq clpA14::minitet) were cotransformed with a pKKUb-X-Pgal plasmid (where X is any amino acid) that expressed a Ub-X-Pgal fusion from the powerful Ptrc promoter and with plasmid pJT184, which encoded the Ub-specific protease Ubpl of S. cerevisiae. X-,Bgal proteins (where X is any amino acid) were purified by APTG-Sepharose chromatography as described previously (19 175, 1993 Nucleotide sequence accession number. The nucleotide sequence reported in this paper has been submitted to the GenBank-EMBL data bank and assigned accession number L10383.
RESULTS
Screen for mutations in the N-end rule pathway. We used transposon mutagenesis to identify genes whose inactivation perturbs the N-end rule pathway in E. coli. Mutagenesis was performed with a strain that expressed both the Ub-Arg-pgal fusion protein and Ubpl, one of the Ub-specific processing proteases of S. cerevisiae (3, 43) (see Materials and Methods). When expressed in E. coli, the yeast Ubpl protease efficiently and precisely deubiquitinates Ub-Arg-pgal and the other Ub-X-Pgal fusions, Ub-Pro-pgal being the single exception (43) . These Ub fusions were not deubiquitinated in E. coli lacking yeast Ubpl, and the unprocessed fusions were invariably long-lived. In contrast, the X-IBgal proteins produced from Ub-X-Pgal fusions in Ubpl-expressing E. coli were either long-lived or unstable, depending on the identity of their N-terminal residues. These measurements, carried out with 19 Ub-X-IBgal fusions, yielded the N-end rule in E.
coli (42) .
Arg-Pgal bears one of the two secondary destabilizing N-terminal residues in the E. coli N-end rule (secondary destabilizing residues require N-terminal conjugation of a primary destabilizing residue prior to substrate degradation).
Therefore, Arg-Pgal could serve as a reporter for detecting changes in the activity of the N-end rule pathway toward substrates bearing either secondary or primary destabilizing N-terminal residues. Transposon insertions into the E. coli chromosome that inhibited the degradation of Arg-IBgal were generated by TnlO mutagenesis by the X-hop method (46) . In this procedure, cells are infected with a nonreplicating, nonintegrating X phage carrying the TnlO transposase and a short (-2-kb), TnlO-derived transposable element (minitet) containing the tetracycline resistance gene of TnlO (46) . A hop of minitet results in a tetracycline-resistant (Tetr) colony. Among such Tetr cells may be minitet insertion mutants unable to degrade Arg-IBgal. Such mutants are identifiable as those that form blue colonies on plates containing X-Gal, a chromogenic indicator of P3gal activity. Cells that degrade Arg-Pgal efficiently do not accumulate significant steadystate levels of Pgal and therefore form white colonies on X-Gal plates (5, 42) .
Approximately 1 in 1,500 minitet insertions rendered E. coli MC1061 unable to degrade Arg-Pgal. Examination of the ability of the mutant to degrade Leu-pgal, which bears one of the primary destabilizing N-terminal residues (requiring no modification prior to substrate degradation) divided these minitet insertions into two classes. Class I mutations failed to degrade both types of N-end rule substrates, represented by Arg-IBgal and Leu-,3gal, while class II mutants were unable to degrade Arg-Pgal but were unimpaired in the degradation of Leu-Pgal.
Insertions that stabilize both Arg-fgal and Leu-pgal reside in the cipA gene. Genomic DNA fragments containing a minitet insertion from class I mutant TS357 were isolated and sequenced as described above. A comparison of the E. coli DNA adjacent to minitet in mutant TS357 with sequences in data bases showed that the transposon resided within previously analyzed cipA. The cipA gene encodes one of the two subunits of ATP-dependent protease Clp (26, 27) . We conclude, in agreement with earlier findings (42) , that the Clp protease is essential for the degradation of N-end rule substrates.
Insertions that stabilize Arg-,3gal but not Leu-jpgal reside in the aat gene. A minitet insertion from mutant TS351 that stabilized Arg-ogal but not Leu-fgal was found to reside within a previously sequenced region of the E. coli chromosome; we also sequenced this region, as well as an adjoining, previously unsequenced -1.5-kb stretch (see Materials and Methods, Fig. 1 , and reference 12). Our earlier work (42) suggested that the insertion in TS351 inactivated a gene for LIF-transferase, a biochemically characterized enzyme that conjugates Leu or Phe to N termini of proteins or peptides bearing N-terminal Arg or Lys (40) . Indeed, an E. coli mutant (MS845 aat-1) that lacked L/F-transferase activity (41) was recently shown to have an N-end rule defect indistinguishable from that in the minitet-generated class II mutant in the present work (stabilization of Arg-Pgal but not of Leu-fBgal) (42) . Mapping experiments with both Hfr mating and P1 transduction demonstrated that the sites of our class II minitet insertions, such as the one in TS351, were indeed extremely close to the site of an aat mutation identified earlier (MS845 aat-1 produced by chemical mutagenesis) in a gene termed aat by Soffer and Savage (41) . These sites and the cipA gene both mapped at -19 min in the E. coli genome (see Materials and Methods). Southern hybridization to genomic DNA from class I (TS354 and TS357) and class II (TS351 and TS353) mutants with minitet as a probe indicated that all insertions resided in the same -10-kb BamHI fragment (data not shown). Furthermore, polymerase chain reaction mapping with genomic DNA isolated from the TS351 and TS353 (class II) mutants and oligonucleotide primers complementary to the 3' end of cipA and to the tet gene of minitet (see Materials and Methods) demonstrated that the transposon insertions of TS351 and TS353 were within -1.5 kb of the 3' end of cipA (data not shown).
aat gene. DNA fragments encompassing cipA and the downstream region of the E. coil genome were isolated from phages 212 and 213 of the Kohara library (30), and an -3.5-kb region downstream of cipA was sequenced. The minitet insertion in mutant TS351 that resulted in the inhibition of Arg-,gal degradation resided within an ORF of a gene (aat) that encoded a neutral (calculated pI, 7.2) 234-residue protein ( Fig. 1 ) whose molecular mass was close to the reported molecular mass of the isolated L/F-transferase (40) . The position of the start (ATG) codon in aat was inferred so as to yield the longest ORF. This start codon was preceded by a moderately strong Shine-Dalgarno sequence, GGAG (Fig. 1) .
The deduced amino acid sequence of the Aat protein lacks significant similarities to the sequence of Atel, the catalytically similar R-transferase of S. cerevisiae shown previously to be a component of the N-end rule pathway in eukaryotes (4) . As expected for an enzyme that interacts with RNA, the aat-encoded L/F-transferase contains arginine-rich regions; however, it lacks known RNA-binding motifs, such as those seen in transcriptional termination factors (31) . In addition, the sequence of Aat lacks "signature" sequences of aminoacyl-tRNA synthetases (10) and also is not similar to other sequences in the current data bases. Thus, it is likely that LF-transferase recognizes tRNA moieties of Leu-tRNAJPu and Phe-tRNAPhe in a novel manner. As described below, the -1-kb DNA fragment containing exclusively the aat ORF complemented the Arg-ogal degradation defect in both the TS351 mutant (minitet insertion) and the original aat mutant (produced by chemical mutagenesis) (41 2, cipA and aat are separated by previously characterized gene infA, which encodes translational initiation factor Infl, and by the serW gene, which encodes tRNAS"r. There are putative transcriptional terminators between the 3' end of infA and the 5' end of serW (12) and between the 3' end of serW and the 3' end of the convergently transcribed cipA gene (21 (17) is shown in Fig. 3 (Fig. 3) . In addition, the N-terminal half of each protein contains several stretches of hydrophobic residues that are likely to be membrane-spanning segments. The ATP-binding motif (23) (48) , is present between the Shine-Dalgarno sequence and the start codon of the aat gene, an unlikely position for a transcriptional terminator. Deletion analyses, described below, confirmed that this region allows readthrough transcription and corroborated earlier data from S1 nuclease mapping experiments carried out during studies of the transcriptional regulation of the infA gene (12) , which is located between aat and cipA (Fig. 2) . These studies demonstrated that the aat gene (referred to as ORF-27 in reference 12) was transcriptionally coupled to an upstream region that contained the mdrH ORF of the present work. In contrast, the infA gene was shown to be expressed from two moderately strong promoters located downstream of aat. As a result, the infA gene is transcribed at a much higher level than its upstream neighbors (12) . We conclude that the aat gene is the last gene of a new operon that contains at least one other gene. Evidence for an intraoperon promoter upstream of the aat gene. The transcriptional coupling of aat to mdrH suggests that the physiologically relevant promoter for L/F-transferase expression resides far upstream of the aat gene. However, ColEl plasmid-based clones containing either the BglII (1366)-ScaI (3077) or the BglII (1366)-SspI (2791) fragment and encoding the entire aat gene but only a fraction of the upstream mdrH gene were found to complement the Arg-Ogal degradation defect of TS351 cells. Furthermore, the sequence immediately upstream of the aat ORF (Fig. 1) resembles the consensus sequence of a a70-dependent E. coli promoter (25) , suggesting that aat could be expressed from either a polycistronic mRNA (see above) or a monocistronic message initiated immediately upstream of aat. We used exonuclease III digestion to define the sequences that are essential for the above-described complementation.
The extent of exonuclease III-mediated deletions and the appearance of colonies of TS351(pUBP-R-Pgal) cells transformed with the recircularized deletion products are shown in Fig. 4 . A reduced colony size was observed for cells transformed with the majority of the clones produced in this deletion series (Fig. 4A) . The growth defect resulted from the inclusion of a complete copy of the infA gene on a multicopy plasmid (see below). Curiously, previous studies done with a different genetic background revealed no growth defect in cells that overexpressed the Infl protein (12) . The origin of this discrepancy remains to be determined. The results from the initial deletion series were unexpected in that clones W2 and W3, which complemented fully TS351 cells for Arg-Ogal degradation, and clones M7 to M12, which complemented partially, were all shorter than the complete aat ORF (Fig. 4A) . A resolution of this paradox is suggested by noting the reading frames of active or partially active clones in Fig. 4A . Deletion clones W2, M7, M8, M9, and Mll all started in the reading frame identical to the aat OFR, while clones W3, M10, and M12 started in the -1 reading frame. Conversely, clone B13, which showed no complementation, contained more upstream DNA than the partially complementing clones but started in the + 1 reading frame. We therefore suspected that the expression of functionally active L/F-transferase from these truncated aat fragments was dependent on plasmid-encoded transcription and translation signals and that a cryptic Shine-Dalgarno sequence and start codon existed only in the 0 and -1 reading frames.
The results of other aat expression tests were consistent with this explanation. Specifically, the PvuII (pGEM2 polylinker)-SspI (2791) fragments from clones W1 and W3 were isolated and cloned into the EcoRV site of plasmid pBR322. This approach has the potential to position the aat ORF in either orientation inside the tet gene of pBR322. However, no clones in which the aat gene was positioned in the sense orientation with respect to the tet gene were recovered for either fragment. Isolation and retransformation of the resulting plasmids into TS351 cells that carried pUBP-R-Pgal resulted in white colonies for the Wi-derived pAS31 vector (complementation of the Arg-Pgal degradation defect) and blue colonies for the W3-derived pAS32 vector (lack of complementation; see Materials and Methods). We conclude that the entire aat ORF and more than 30 bp of upstream DNA are required for L/F-transferase expression in this environment. Furthermore, the complete absence of clones in which the aat gene was positioned in the same orientation as the disrupted tet gene (data not shown) suggested that overexpression of L/F-transferase from multiple copies of the pBR322 Pte, promoter is deleterious to the cell. Interestingly, the ability of plasmids expressing the M7 or M11 fragment of aat to complement partially the Arg-,Bgal degradation defect in TS351 cells (Fig. 4A) indicated that a deletion of the N-terminal -15% of L/F-transferase does not completely abolish its enzymatic activity.
A second deletion series was created to define more precisely the sequences required for L/F-transferase expression. In this series, four copies of the transcriptional terminator from the E. coli rRNA operon (9) were positioned immediately upstream of the deletion clones to reduce the influence of the plasmid-based expression signals that complicated interpretation of the data obtained with the first deletion series. As shown in Fig. 4B , clones as long as T14-2 and T14-6 did not complement the TS351 mutant, while clone T14-18 (which contained the complete aat ORF and 83 bp of the upstream sequence) resulted in full complementation, as judged by colony color on X-Gal plates. The constraints provided by these deletion data, as well as similarities between the known cr70-dependent E. coli promoters and the -50-bp region immediately upstream of the aat ORF, indicated that this region functioned as a promoter in plasmidbased constructs. The relative contribution of this intraoperon promoter to the in vitro expression of L/F-transferase remains to be determined. the plasmids generated in the first deletion series (see above and Fig. 4A ) formed smaller colonies than transformants carrying either the plasmids generated in the second deletion series or plasmid pAS31 (or pAS32), which had aat inserted within the tet gene. The growth deficiency caused by the first series of plasmids stemmed from the presence of the infA gene in the BglII (1366)-ScaI (3077) fragment (Fig. 1) used to isolate the deletion fragments shown in Fig. 4A . Indeed, plasmids such as pAS45, derived from the BglII (1366)-SspI (2791) fragment, which encoded only an N-terminal region of the Infl protein, did not confer a slow-growth phenotype (data not shown). Furthermore, transformation of TS351 (aat-2::minitet) with pAS25, which was produced from pAS17 (see Materials and Methods) by deletion of its 346-bp KpnI (2458 to 2806) fragment (Fig. 1) , yielded large blue colonies on X-Gal plates. The latter deletion removed the sequences encoding the last 8 residues of L/F-transferase through those encoding the first 11 residues of Infl ( Fig. 1  and data not shown) . Thus, multiple copies of the infA gene appear to be deleterious, at least in the backgrounds of the tested E. coli strains. In addition, the lack of complementation by plasmid pAS25 showed that even small deletions at the C terminus of L/F-transferase abolish its activity.
In vivo modification of Arg-j3gal. Previous evidence that the degradation of the engineered N-end rule substrate Arg-fgal proceeds through a (Phe or Leu)-Arg-,Bgal intermediate was largely indirect. A functional aat gene is required for the degradation of Arg-Ogal and Lys-,gal in E. coli, whereas the degradation of Phe-3gal and Leu-Pgal is independent of aat (42) . To test directly for the N-terminal modification of an N-end rule substrate, Arg-Pgal was overexpressed in and purified from E. coli JT111 cells (see Materials and Methods). This strain is aat+ but contains a clpA14::minitet mutation that blocks the degradation of all N-end rule substrates (42) and thus allows their overexpression. The results of N-terminal sequencing of the isolated Arg-Pgal confirmed the role of L/F-transferase in the in vivo degradation of Arg-jgal but were also unexpected in several respects. In the presence of isopropyl-p-D-thiogalactopyranoside (IPTG), the initial fusion, Ub-Arg-pgal, was expressed to near toxic levels from the Ptrc promoter. Nonetheless, the bulk of Ub-Arg-,3gal was deubiquitinated by the Ubpl protease (expressed from plasmid pJT184; 43). Moreover, -70% of the resulting Arg-,gal was modified by L/F-transferase, a nonabundant enzyme (14) produced from a scarce mRNA (12) . In contrast to the results of in vitro studies with partially purified L/F-transferase, which catalyzed the efficient conjugation of either Phe or Leu (and the less efficient conjugation of Met) to the N termini of test substrates (14) , the N-terminal modification of Arg-3gal in vivo was found to involve exclusively the conjugation of Leu (Materials and Methods and data not shown). Thus, the in A VOL. 175, 1993 vivo selectivity of L/F-transferase is greater than that observed with the isolated enzyme.
DISCUSSION
We have extended our previous observation that L/Ftransferase is a component of the N-end rule pathway in E. coli (42) . The involvement of L/F-transferase in proteolysis mirrors a similar involvement of R-transferase in the N-end rule pathway of eukaryotic cells. In either pathway, the N-terminal conjugation of a primary destabilizing amino acid serves as a signal for the degradation of the modified protein.
Although each of these aminoacyl-tRNA-protein transferases catalyzes the posttranslational N-terminal aminoacylation of acceptor proteins, their amino acid sequences are dissimilar from one another and from other sequences in current data bases. Furthermore, bacterial L/F-transferase is about half the size of yeast R-transferase (234 versus 503 residues) (4) ; it is also considerably smaller than the smallest aminoacyl-tRNA synthetase (10) . The small size of E. coli LIF-transferase is particularly noteworthy in light of the demonstrated ability of the enzyme to bind specific aminoacyl-tRNAs, to discriminate between cognate and noncognate aminoacyl residues in a mischarged aminoacyltRNA, to recognize specific N-terminal residues in substrates of L/F-transferase, and to catalyze peptide bond formation (40) . On the basis of our deletion analysis, the enzymatic activity of L/F-transferase depends only weakly on the presence of the N-terminal -15% of its sequence, whereas even small C-terminal deletions abolish the activity.
The in vivo specificity of L/F-transferase differs from that determined previously with a partially purified enzyme or whole-cell extracts. In vitro, L/F-transferase catalyzes the conjugation of Phe, Leu, or (at lower levels) Met residues to the N termini of proteins bearing N-terminal Lys or Arg (40 (40) suggests that additional subunits would be limited to a regulatory role. Consistent with the existence of additional subunits are biochemical data indicating that LIF-transferase activity fractionates as a highmolecular-mass complex (>25 kDa) during gel chromatography of crude E. coli extracts (14) .
The greater specificity of L/F-transferase in vivo (compared with the findings obtained with cell-free enzymatic assays) was also suggested by our previous in vivo findings (42) . In in vitro studies, the dipeptides Arg-Ala, Lys-Ala, and (at higher concentrations) His-Ala were found to inhibit the aminoacylation of ac-casein catalyzed by L/F-transferase (a-casein contains an N-terminal Arg residue) (40) . No other dipeptide of the form X-Ala could inhibit this reaction. These results were interpreted to mean that N-terminal His could act as a substrate for N-terminal aminoacylation by LIFtransferase. However, the in vivo half-life of His-,gal in E. coli was found to be indistinguishable from those of the other long-lived X-,gal proteins (42) , indicating that L/F-transferase-mediated aminoacylation of His-,gal (and its subsequent degradation by the Clp protease) was negligible in vivo.
The possibility that the presently known set of components of the N-end rule pathway in E. coli is incomplete is consistent with our inability to reconstruct the N-end rule pathway in vitro. Assays with purified Clp protease (a gift from M. Maurizi, National Institutes of Health) and purified X-fBgal proteins yielded little degradation of X-Pgal proteins and no differential degradation that depended on the identity of an N-terminal residue (data not shown). This result may have been due to the absence of a putative N-recognin-like component in these assays. In the eukaryotic N-end rule pathway, an N-recognin (also called E3) binds to a primary destabilizing N-terminal residue of an N-end rule substrate and initiates a cascade of reactions that result in substrate degradation (5).
We have screened for mutations that stabilize Arg-Pgal in E. coli by using both transposon mutagenesis and the chemical mutagen ethyl methanesulfonate. To date, these screens have identified only the clpA and aat genes as components of the N-end rule pathway. Although this result would normally suggest that a screen is saturated, these screens have failed to yield mutations in clpP, which encodes the second subunit of the Clp protease (33) . A constructed E. coli strain in which the central 55% of the clpP gene was replaced with a kanamycin resistance marker yielded blue colonies when transformed with either pUBP-R-Pgal or pUBP-L-IPgal, demonstrating that clpP is also essential for the degradation of N-end rule substrates in E. coli. The failure of our screens to identify an E. coli N-recognin might have resulted from this protein having an additional function that is essential for cell viability (inactivation of the N-end rule pathway is not lethal; 42) or from the existence of multiple, functionally overlapping N-recognins in E. coli. Recently, a selectionbased screen in which the modified TnS Kan protein, which specifies kanamycin resistance, was used as an N-end rule reporter substrate was developed. This screen, which did reveal an N-end rule-inactivating mutation in the clpP gene, is being used to search for other components of the N-end rule pathway (31a).
The aat gene maps to 19 min of the E. coli chromosome. This definitive position differs from a previous tentative mapping of aat to -55 min (41) . We have shown that aat is the last gene of a new operon that contains at least one additional ORF, termed mdrH. The deduced amino acid sequence encoded by the mdrH ORF is highly similar to the sequences of mammalian Mdr P glycoproteins. Other examples of mdrH homologs from bacteria include the hylB gene, required for hemolysin transport in uropathogenic E. coli strains (7) , and the cyaB gene, implicated in the export of the calmodulin-sensitive adenylate cyclase-hemolysin bifunctional protein of B. pertussis (17) . E. coli MdrH is also homologous to a family of bacterial membrane importers. These proteins, which include OppF and HisP, share a putative ATP-binding motif (23) with genes from the Mdr family (23) . The sequence of MdrH is more similar to that of CyaB than it is to the sequences of bacterial importers involved in the membrane transport of small metabolites, suggesting that MdrH mediates the translocation of (unknown) peptides or proteins across an E. coli membrane (23) .
The transcriptional coupling of mdrH and aat suggests a functional connection between the enzymes encoded by these genes. This possibility is particularly interesting in light of recently published mapping data (13) . The genes cydC and cydD have been localized on the E. coli chromo-some to the region immediately adjacent to the infA gene, which encodes translational initiation factor Infl. In the published map (13) , the positions of cydC and cydD (13) appear to be identical to the positions demonstrated here to contain, respectively, aat and mdrH (Fig. 2) . The cydC and cydD genes do not encode known components of the cytochrome d enzyme but are nonetheless essential for the expression of a functional cytochrome d (16, 35) . Cytochrome d is a terminal oxidase that mediates E. coli respiration under conditions of low oxygen tension. Interestingly, at high oxygen tensions, this enzyme is replaced by the cytochrome o terminal oxidase. Thus, the replacements of specific terminal oxidases in response to changing oxygen tensions might involve L/F-transferase-dependent degradation of an old cytochrome or L/F-transferase-dependent transport of a new cytochrome to its position in the inner membrane. However, recent tests of these possibilities indicated that aat is distinct from cydD, because a mutant bearing a precise deletion of the aat gene did not have the phenotypes characteristic of mutations in cydD or functionally related genes (31a).
